JAVMA news
Compounded equine drugs seized from Kentucky pharmacy
On Aug. 12, U.S. marshals seized compounded equine drugs from a Kentucky pharmacy
JAVMA news
Reminder: ECP not approved for use in animals
The Food and Drug Administration's Center for Veterinary Medicine has received reports that certain pharmacies and veterinarians have compounded…
JAVMA news
FDA issues booklet reviewing information on animal health care needs
The Center for Veterinary Medicine within the Food and Drug Administration published a pamphlet in August titled "FDA and the Veterinarian."
JAVMA news
Compounding issues resurface in wake of ponies' deaths
The high-profile deaths of 21 polo ponies at the U.S. Open Polo Championship, caused by an overdose of selenium, has brought the issue of
JAVMA news
FDA’s Dunham delves into drug issues
Dr. Bernadette Dunham, director of the Food and Drug Administration’s Center for Veterinary Medicine, recently fielded questions about drug issues and…
JAVMA news
Changing the rules for pharmacy
The ever-changing state and federal rules governing pharmacy within veterinary medicine were the subject of a wide-ranging session during the 2014…
Cannabis: FAQs for veterinarians
Get answers to frequently asked questions about the regulatory status of cannabis, cannabis-derived, and cannabis-related products in veterinary…
blog
AVMA voices veterinary needs to FDA about cannabis products
The U.S. Food and Drug Administration (FDA) should provide regulatory clarity about expectations for the labeling, safety, and use of cannabis-derived…
JAVMA news
FDA describes legal limits of drug compounding
Agency says few uses allowed for raw active ingredients
JAVMA news
FDA warns companies illegally selling CBD products
Agency signaled that it cannot conclude cannabidiol is safe.
resource
AVMA request: Commenting deadline for compounding
JAVMA news
Board chair embraces veterinary family ties
Dr. Rena Carlson, chair of the AVMA Board of Directors, has held leadership roles since early in her veterinary career. She spoke to JAVMA News about…
blog
AVMA prepares response to FDA draft compounding guidance
Based on feedback from member veterinarians and other stakeholders, the AVMA has compiled a list of key points to share with the FDA in our formal…
JAVMA news
The hype and hope of veterinary cannabis
A range of issues were covered at the first AVMA Cannabis Symposium, from regulatory and toxicological concerns to the drug’s potential as a…
JAVMA news
HOD passes resolution on workforce issues
AVMA leaders resolved to help address economic, staffing, and morale challenges in the veterinary workforce and they adjusted a series of existing…
Compounding from bulk drug substances
Learn about GFI #256, which clarifies the circumstances under which FDA does not intend to pursue enforcement action for compounding animal drugs from…
AVMA news
Clash between California veterinary, horse racing boards keeps equine practitioners guessing
The California Horse Racing Board and California Veterinary Medical Board are working through differences in how each is interpreting and enforcing…
AVMA news
AVMA House of Delegates approves eight resolutions
The AVMA House of Delegates approved eight resolutions on Jan. 7 during its regular winter session, held in conjunction with the AVMA Veterinary…
AVMA news
FDA: Congress, not rule-making, likely route for CBD availability
With the cannabidiol products market continuing to grow and after reviewing published scientific literature and information submitted to a public…
AVMA news
USP revised compounding standards go into effect
Revised compounding standards from the United States Pharmacopeia (USP) became effective November 1 after 12 years of work. According to the USP, the…
AVMA news
HHS, senators request DEA reschedule marijuana
Legislators are seeking to remove marijuana from the Controlled Substances Act (CSA) after the U.S. Department of Health and Human Services (HHS)…